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Summary
Extracellular antigens are internalized and processed
before binding MHC class II molecules within endoso-
mal and lysosomal compartments of professional an-
tigen presenting cells (APC) for subsequent presenta-
tion to T cells. Yet select cytoplasmic peptides derived
from autoantigens also intersect and bind class II
molecules via an unknown mechanism. In human B
lymphoblasts, inhibition of the peptide transporter as-
sociated with antigen processing (TAP) failed to alter
class II-restricted cytoplasmic epitope presentation.
By contrast, decreased display of cytoplasmic epi-
topes via class II molecules was observed in cells
with diminished expression of the lysosome-associ-
ated membrane protein-2 (Lamp-2). Overexpression
of Lamp-2 isoform A (Lamp-2a), an established com-
ponent of chaperone-mediated autophagy, enhanced
cytoplasmic autoantigen presentation. Manipulat-
ing APC expression of heat shock cognate protein
70 (hsc70), a cofactor for Lamp-2a, also altered cyto-
plasmic class II peptide presentation. These results
demonstrate a novel role for the lysosomal Lamp-2a-
hsc70 complex in promoting immunological recogni-
tion and antigen presentation.
Introduction
CD4 T cells recognize peptide-MHC class II complexes
displayed on APC, leading to the activation or anergy
of host cellular immune responses. Whereas class II
molecules function in protective immunity against bac-
terial and protein antigens exogenously delivered into*Correspondence: jblum@iupui.eduAPC, autoantigen presentation by these MHC mole-
cules is also critical for the induction of self tolerance.
Class II molecules transit endosomal compartments en
route to the cell surface, thus favoring their acquisition
of both foreign- and self-peptide ligands generated
within acidic endosomes and lysosomes. Yet, there is
also evidence that class II molecules potentiate CD4 T
cell responses to endogenous antigens in tumor and
virally infected cells (Jacobson et al., 1989; Jaraque-
mada et al., 1990; Wang et al., 1999). Biochemical
studies have revealed peptide ligands derived from cy-
toplasmic and nuclear antigens bound to MHC class II
molecules (Chicz et al., 1993; Rudensky et al., 1991).
Cytoplasmic processing by proteases is required for ef-
ficient presentation of these autoantigens to CD4 T
cells, although the mechanisms responsible for deliver-
ing peptides to vesicular compartments rich in MHC
class II molecules remain poorly defined (Lich et al.,
2000).
TAP delivers cytosol-derived peptides into the endo-
plasmic reticulum (ER) for binding to MHC class I mole-
cules. Studies with viral antigens and B lymphoblasts
suggest that TAP is not involved in the transport of cy-
toplasmic peptides to MHC class II molecules (Malnati
et al., 1993, 1992). A small protein derived from herpes
simplex virus, ICP47, has been shown to bind to TAP
and block peptide transport into the ER (Fruh et al.,
1995; Hill et al., 1995). To elucidate the role of TAP in
cytoplasmic autoantigen presentation via class II pro-
teins, ICP47 was expressed in APC. T cell activation
assays with ICP47-expressing B cells confirmed no al-
teration in MHC class II-restricted presentation of two
cytoplasmic autoantigens.
A system, chaperone-mediated autophagy, that me-
diates the transport of cytoplasmic peptides and pro-
teins directly into endosomes and lysosomes has been
identified in hepatocytes and fibroblasts under resting
conditions and in response to metabolic stress (Chiang
et al., 1989; Cuervo and Dice, 1996). Two essential com-
ponents of this pathway are the Lamp-2a isoform and
the heat shock cognate protein 70 (hsc70), formerly
termed hsc73. Lamp family members are conserved
transmembrane glycoproteins predominantly localized
in prelysosomes and lysosomes. Due to alternative
splicing, human Lamp-2 has at least two isoforms,
Lamp-2a and Lamp-2b (Konecki et al., 1995). Studies
in rodent cells suggest that Lamp-2a, but not Lamp-2b,
functions in delivering proteins from the cytoplasm to
lysosomes (Cuervo and Dice, 2000). A model has been
proposed whereby an accessory chaperone, hsc70, in-
tersects target proteins in the cytoplasm and facilitates
their delivery to Lamp-2a, residing in the membrane of
lysosomes. Studies in hepatocytes and fibroblasts indi-
cate both Lamp-2a and hsc70 serve essential functions
in protein translocation into lysosomes, yet the role of
this transporter complex in immunological responses
has not previously been investigated. To address this
question, cellular levels of Lamp-2a and hsc70 in APC
were altered. Functional assays with these cells re-
vealed corresponding changes in the presentation of
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572cytoplasmic antigens and peptides, suggesting that the s
cLamp-2a:hsc70 pathway promotes the intersection of
cytoplasmic peptides with MHC class II molecules. i
f
oResults
p
tInhibition of TAP Function Did Not Affect
dCytoplasmic Antigen Presentation
2by MHC Class II Molecules
vThe human B lymphoblastoid cell line (B-LCL) PriessGAD
(constitutively expressing the cytoplasmic antigen glu-
(tamate decarboxylase (GAD) was stably transfected
twith a plasmid encoding the TAP inhibitor ICP47. Ex-
upression of ICP47 in the transfected PriessGAD cells
twas confirmed by metabolic radiolabeling and immu-
noprecipitation (data not shown). Inhibition of TAP
function was apparent by a significant decrease in cell R
Msurface MHC class I levels, as detected by flow cytom-
etry with cells transfected with this viral protein com- L
ipared to cells containing empty vector (Figure 1A). To
further confirm the functional disruption of MHC class 1
fI antigen presentation in cells expressing the TAP inhib-
itor ICP47, CD8 T cell responses to viral antigens were a
stested with these B-LCL. Class I A2-restricted pre-
sentation of an influenza matrix protein-derived epitope s
Lwas reduced at least 50% when comparing B-LCL with
and without ICP47 expression (Figure 1B). Similarly, a c
L50%–75% reduction in human CTL responses to HLA-
A2 and the BMRF1 antigen from Epstein Barr Virus a
c(EBV) was detected when comparing these B cell lines
with and without ICP47 (data not shown). Analysis of a
tthese B-LCL revealed that cell surface levels of MHC
class II DR were not altered by ICP47 expression (Fig- a
Lure 1A). T cell activation assays with a T cell hybridomaFigure 1. Inhibition of TAP Function Did Not
Perturb Cytoplasmic GAD Presentation by
MHC Class II
(A) Inhibition of MHC class I, but not class II,
protein surface expression after B-LCL
transfection with the TAP inhibitor ICP47.
PriessGAD cells were transfected with a
control vector (pMCFR) or a vector encoding
ICP47. Cells were incubated with the
anticlass I monoclonal antibody w6/32 or the
anti-class II monoclonal antibody L243 fol-
lowed by FITC-conjugated rabbit anti-mouse
IgG. Cells were then analyzed by flow cytom-
etry for surface MHC expression.
(B) Impaired class I antigen presentation in
cells expressing ICP47. B-LCL cells with or
without ICP47 expression were infected with
serial dilutions of influenza A/PR/8/34 (1024
HA units/ml) followed by coculture with 4AV1
T cells recognizing M158–66. Error bars indi-
cate the mean ± the standard deviation.
(C) Class II-restricted presentation of cyto-
plasmic GAD was unchanged with functional
expression of ICP47 in B-LCL. PriessGAD
B-LCL ± transfected ICP47 cDNA or the
empty pMCFR vector was incubated with
33.1 T cells recognizing GAD273–285. Variable
APC:T cells ratios were used. Results are re-
presentative of three independent experi-
ments. Error bars indicate the mean ± the
standard deviation.pecifically recognizing the GAD273–285 epitope in the
ontext of class II HLA-DR4 failed to reveal any change
n cytoplasmic GAD presentation after inhibition of TAP
unction (Figure 1C). Similar studies were also carried
ut with another B cell line, Frev/SMA (FM), stably ex-
ressing cytoplasmic SMA, a mutated form of the au-
oantigen human immunoglobulin (Ig) κ chain, which is
egraded in the cytosol by the proteasome (Dul et al.,
001; Lich et al., 2000). After inhibition of TAP function
ia expression of ICP47, presentation of two κ epitopes
κ188–203 [κI] and κ145–159 [κII]) from SMA was unaltered
data not shown). These results indicated that the
ransport function of TAP does not significantly contrib-
te to MHC class II-restricted presentation of these cy-
oplasmically processed autoantigens in B cells.
eduction in Total Cellular Lamp-2 Levels Decreased
HC Class II-Restricted Antigen Presentation
amp-2a has been suggested as the rate-limiting factor
n chaperone-mediated autophagy (Cuervo and Dice,
996). Here, in human B-LCL, the role of Lamp-2 iso-
orms in class II-restricted presentation of endogenous
nd exogenous antigens was examined. Reverse tran-
criptase-polymerase chain reaction (RT-PCR) analysis
uggested that both the a and b isoforms of human
amp-2 are expressed in primary monocytes, CD19+ B
ells, and B-LCL (data not shown). To test the role of
amp-2 in class II pathways for antigen presentation,
n expression plasmid encoding antisense Lamp-2
DNA was constructed to decrease production of the a
nd b isoforms. PriessGAD cells were transfected with
his cDNA or a control vector, and cell lines with over-
ll decreased Lamp-2 protein levels (PriessGAD/AS-
AMP-2) were selected (Figure 2A). MHC class II levels
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573Figure 2. Decreased Lamp-2 Protein Levels Resulted in Decreased Cytoplasmic GAD Presentation
(A) Decreased Lamp-2 protein levels in antisense-transfected cells. Cell lysates were prepared from PriessGAD cells transfected with the
control vector (PriessGAD/Hygro) or vector encoding Lamp-2 antisense (PriessGAD/AS-LAMP-2). Immunoblot analysis was performed with
antibodies for Lamp-2 or the endogenous antigen GAD65. The Lamp-2 antibody equivalently detects a and b isoforms.
(B) Decreased class II presentation of cytoplasmic GAD by cells with low Lamp-2 levels. PriessGAD/Hygro and PriessGAD/AS-LAMP-2 cells
were incubated with 33.1 T cells at variable APC:T cells ratios for 24 hr, and T cell activation was measured. As a control, APCs were
preincubated with 10 M GAD237–285, and the presentation of exogenous GAD peptide was detected. Error bars indicate the mean ± the
standard deviation. **p < 0.01, Student’s t test.
(C) Decreased class II presentation of exogenous antigen HSA by Lamp-2-low cells. PriessGAD/Hygro and PriessGAD/AS-LAMP-2 cells were
preincubated with increasing concentrations of HSA followed by incubation with 17.9 T cells specific for HSA 64–76. Results are representative
of at least three independent studies. Error bars indicate the mean ± the standard deviation.at the cell surface were unaltered in these transfected
cells, as detected by flow cytometry (data not shown).
The presentation of endogenous GAD in the context of
HLA-DR4 was significantly decreased in these Lamp-
2-low cells (Figure 2B). These functional studies were
confirmed with multiple Lamp-2-low cell lines (data not
shown). In contrast, the presentation of exogenous
GAD273–285 peptide was not affected (Figure 2B). The
presentation of exogenous antigens, such as human
serum albumin (HSA), was also decreased in cells with
reduced Lamp-2a and Lamp-2b (Figure 2C). These re-
sults suggested that Lamp-2 isoforms were involved in
antigen processing and presentation by MHC class II
molecules.
Overexpression of Lamp-2a Increased Cytoplasmic,
but Not Extracellular, Antigen Presentation
via MHC Class II
Lamp-2a and Lamp-2b differ only in their transmem-
brane domains and short cytoplasmic tails, which are
encoded by differential splicing of exon 9 (Konecki et
al., 1995). To dissect the function of the individual iso-
forms and to further elucidate the role of Lamp-2 in an-
tigen presentation, siRNA constructs specific for exon
9 were designed. However, by using these isoform-spe-
cific siRNA, decreases in Lamp-2 isoform levels werenot attainable in B-LCL (data not shown). As an alterna-
tive, cellular overexpression of the individual isoforms
was tested for effects on antigen presentation. Human
B-LCL, PriessGAD, and FM were transfected with a
plasmid encoding either Lamp-2a or Lamp-2b iso-
forms. Stable B cell lines overexpressing Lamp-2a were
generated with enhanced levels of Lamp-2 protein as
confirmed by Western blotting (Figures 3A and 3B). The
total cellular content of cytoplasmic GAD65 antigen
and MHC class II DR as well as cell surface MHC class
II protein levels were unaltered in cells overexpressing
Lamp-2a compared to cells transfected with empty
vector alone (Figures 3A and 3B and data not shown).
Studies of cytoplasmic antigen presentation revealed a
significant increase in class II presentation of endoge-
nous GAD only in cells overexpressing Lamp-2a (Figure
3C). As a control, the presentation of exogenous
GAD273–285 peptide was tested and found not to vary
with changes in cellular Lamp-2a content (Figure 3C).
The presentation of two Ig κ epitopes, κI and κII derived
from the cytoplasmic antigen SMA, was also signifi-
cantly increased by enhanced Lamp-2a expression in
FM cells (Figure 3D). Interestingly, the presentation of
exogenous antigens, including HSA, GAD, and tetanus
toxoid (TT), was not affected by overexpressing Lamp-
2a (Figure 3F and data not shown). PriessGAD cells
Immunity
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(A) Overexpression of Lamp-2a in PriessGAD. Lysates were prepared from PriessGAD cells transfected with a control vector (PriessGAD/
Hygro) or Lamp-2a vector (PriessGAD/LAMP-2a). Immunoblot analysis was performed by using antibodies for Lamp-2, GAD65, and HLA-DR
α chain.
(B) Increased Lamp-2 protein levels were observed in FM cells transfected with Lamp-2a cDNA (FM/LAMP-2a) compared to cells transfected
with a control vector (FM/Zeo).
(C) Increased class II presentation of cytoplasmic GAD by cells overexpressing Lamp-2a. PriessGAD/Hygro and PriessGAD/LAMP-2a cells
were incubated with 33.1 T cells at variable APC:T cells ratios to monitor T cell activation. As a control, APCs were preincubated with 10 M
GAD237–285, and the presentation of exogenous GAD peptide was detected. Error bars indicate the mean ± the standard deviation.
(D) Increased class II presentation of cytoplasmic SMA by cells overexpressing Lamp-2a. Presentation of SMA-derived κI and κII epitopes
was tested with T cells 2.18 and 1.21. Error bars indicate the mean ± the standard deviation.
(E) Presentation of the secretory antigen Ig κ chain was not affected by cellular overexpression of Lamp-2a. PriessGAD/Hygro and PriessGAD/
LAMP-2a cells were incubated with T cells 2.18 and 1.21 followed by analysis of T cell activation. Error bars indicate the mean ± the
standard deviation.
(F) Presentation of exogenous antigen HSA was unaltered by overexpressing Lamp-2a in APC. PriessGAD/Hygro and PriessGAD/LAMP-2a
cells were preincubated with human serum albumin (HSA). APCs were cultured with 17.9 T cells prior to analysis of T cell activation. Results
are representative of three individual experiments. Error bars indicate the mean ± the standard deviation.
*p < 0.05; **p < 0.01, Student’s t test.constitutively produce secretory Ig κ, which serves as n
2an endogenous intravesicular source of antigen. The
presentation of κI and κII epitopes derived from this a
pintravesicular Ig κ chain was not affected by changes
in the cellular content of Lamp-2a (Figure 3E). These w
dresults were further confirmed with multiple Lamp-2a-
high cell lines (data not shown). The role of Lamp-2b in t
Bcytoplasmic antigen presentation was also tested with
B cell lines overexpressing this Lamp-2 isoform (Figure e
54A). Remarkably, neither cytoplasmic nor exogenous
antigen presentation by MHC class II molecules was v
eaffected by Lamp-2b overexpression (Figures 4B–4D).
Together, these studies demonstrate that Lamp-2a, but n
wnot Lamp-2b, functions specifically in promoting cyto-
plasmic antigen presentation by MHC class II mole- t
pcules.
Lamp-2 proteins are expressed at low levels on the L
csurface of cells relative to their distribution in endo-
somes and lysosomes. Increased levels of Lamp-2 are e
pfound on the surface of metastatic tumors, possibly
suggesting that Lamp-2 isoforms function as adhesion a
amolecules (Saitoh et al., 1992). In Lamp-2a-overex-
pressing B cell lines, surface Lamp-2 levels were also (
iincreased slightly as detected by flow cytometry (dataot shown). To test whether enhanced surface Lamp-
a promotes T cell and B cell interaction, thus affecting
ntigen presentation, the following experiment was
erformed. B cells were aldehyde fixed and incubated
ith increasing concentrations of GAD273–285 peptide to
irectly load this ligand onto surface class II proteins in
he absence of endocytosis. The ability of these fixed
cells to activate T cells was not altered regardless of
nhanced B cell surface expression of Lamp-2a (Figure
A). Studies with live B lymphoblasts also failed to re-
eal any change in the presentation of surface-loaded
xogenous peptides with Lamp-2a overexpression (data
ot shown). In addition, blocking B cell surface Lamp-2
ith specific antibodies had no effect on T cell activa-
ion in response to epitopes derived from either cyto-
lasmic or exogenous antigens (data not shown).
amp-2a overexpression in APC did not induce any
hange in overall cell morphology as detected with
lectron microscopy (data not shown). Nor did overex-
ression of the Lamp-2a isoform alter the content of
utophagic vacuoles in cells, as determined with the
utophagosome marker monodansylcadaverine (MDC)
Figure 5B). Further analysis of Lamp-2a overexpress-
ng cells also failed to reveal any measurable change in
Lysosomal Membrane Protein and Antigen Transport
575Figure 4. Overexpression of Lamp-2b in APC
Had No Effect on MHC Class II-Restricted
Antigen Presentation
(A) Enhanced Lamp-2 protein levels were de-
tected in B-LCL after transfection with a
plasmid encoding Lamp-2b. FM cells were
transfected with pCDNA3.1/Zeo(−) encoding
Lamp-2b cDNA (FM/LAMP-2b) or a control
vector (FM/Zeo). Cell lysates were subjected
to immunoblot analysis with antibodies spe-
cific for Lamp-2, HLA-DR α chain, and
GAPDH.
(B and C) Cytoplasmic SMA presentation
was not altered by overexpressing Lamp-2b.
APCs (FM/Zeo and FM/LAMP-2b) were incu-
bated with 2.18 and 1.21 T cells at the ratios
indicated for 24 hr. T cell activation was de-
tected as described previously. Error bars in-
dicate the mean ± the standard deviation.
(D) Extracellular antigen (HSA) presentation
was not altered by overexpressing Lamp-2b.
FM/Zeo and FM/LAMP-2b cells were prein-
cubated with increasing concentrations of
HSA followed by culturing with 17.9 T cells.
T cell activation was measured. Representa-
tive results from three studies are shown. Er-
ror bars indicate the mean ± the standard
deviation.lysosomal protease maturation or distribution (Figures
5C and 5D). Thus, consistent with the lack of change in
class II exogenous antigen presentation, cathepsin D
maturation and subcellular distribution were unchanged
in APC overexpressing Lamp-2a.
Alteration of hsc70 Level Affected Class II
Presentation of Cytoplasmic Antigens
The chaperone protein hsc70 has been demonstrated
to cooperate with Lamp-2a in transporting proteins
from the cytoplasm into lysosomes. To directly test the
role of hsc70 in MHC class II-restricted cytoplasmic an-
tigen presentation, PriessGAD cells were transfected
with plasmids encoding human hsc70 sense or anti-
sense DNA. Hsc70 is very abundant in cells, often rep-
resenting 1%–2% of the total cellular protein (Newmyer
and Schmid, 2001). The abundance of hsc70 in cells
may limit overexpression of this molecule, yet in several
independent B cell transfectants a slight increase in the
total cell content of hsc70 could be detected (Figure
6A, insert). B cells transfected with antisense DNA for
hsc70 were found to contain reduced levels of this
heat-shock-like protein (Figure 6A, insert). Analysis of
class II-restricted cytoplasmic antigen presentation re-
vealed that cells transfected with hsc70 sense DNA dis-
played increased cytoplasmic GAD presentation, whereas
cells transfected with hsc70 antisense DNA had slight
decreases in GAD antigen presentation (Figure 6A). Al-
tering cellular hsc70 levels had no significant effect on
B cell presentation of exogenous antigens such as HSA
(data not shown). These results suggest that hsc70 can
modulate MHC class II-restricted cytoplasmic Ag pre-
sentation. Both the chaperone hsc70 and the lysosomal
membrane protein Lamp-2a have been observed to
bind to select cytoplasmic substrates, potentially to en-
hance transport and proteolytic processing. Here, in
GAD-expressing APC, monoclonal antibodies wereused to precipitate this self antigen, and Western blot-
ting analyses were performed to detect the presence of
bound hsc70 and Lamp-2. Results indicate that each
of these molecules can be detected complexed with
GAD autoantigen (Figure 6B).
Overexpression of Lamp-2a Increased Transport of
Cytoplasmic GAD Peptide to Class II Complexes
To directly test the possible role of Lamp-2a in the
translocation of antigenic peptides, the GAD273–285
peptide was electroporated into the cytoplasm of FM
cells with or without Lamp-2a overexpression. Electro-
porated cells were then monitored for peptide binding
and presentation via class II proteins. Presentation of
the peptide via class II HLA-DR4 was detected only in
electroporated cells, suggesting that delivery of the
epitope into the cytoplasm of cells was required prior
to translocation and class II binding. T cell responses to
APC electroporated with the GAD273–285 peptide were
enhanced nearly 2-fold in cells overexpressing Lamp-2
compared to control cells (Figure 7A). To detect the for-
mation of MHC class II and GAD peptide complexes
directly, C terminus biotin-labeled GAD273–285 peptide
was introduced into the cytosol of APC by electropora-
tion followed by incubation for 16 hr. Stable peptide-
class II complexes can be detected on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
migrating as molecular complexes with an apparent
molecular mass of 60 kDa. Such complexes containing
the biotinylated GAD273–285 peptide were observed af-
ter peptide electroporation into the cytoplasm of cells
(Figure 7B). In agreement with functional studies, the
relative abundance of these GAD peptide-class II com-
plexes was increased in cells overexpressing Lamp-2a.
These results support the hypothesis that Lamp-2a
overexpression in B cells enhances epitope delivery
from the cytoplasm into endosomal and lysosomal
Immunity
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aIn control studies, the 60 kDa peptide complexes were
not detected in peptide-electroporated cells lacking t
fclass II molecules (Figure 7C). Also, immunoprecipita-
tion of cell lysates with antibodies specific for class II c
nmolecules resulted in the depletion of these peptide-
class II complexes, again confirming the specificity of i
tthis assay (Figure 7D). Loading of cytoplasmic GAD
peptides onto MHC class II was a slow process, with p
pcomplex formation readily detectable 8 hr after electro-
poration (Figure 7E). These results demonstrate a role 1
sfor Lamp-2a in facilitating the delivery of peptides from
the cytoplasm to MHC class II molecules. m
b
fDiscussion
M
LBiochemical and functional studies of professional and
nonprofessional APC have identified epitopes derived f
tfrom cytoplasmic antigens presented in the context of
both murine and human MHC class II molecules (Chicz t
et al., 1993; Lich et al., 2000; Malnati et al., 1993, 1992;
Rudensky et al., 1991). These epitopes are drawn from i
pa diverse pool of cytosolic antigens including metabolic
enzymes, cytoskeletal proteins, viral and tumor anti- s
fgens, misfolded proteins, and molecules bound to the
cytoplasmic face of endosomes and lysosomes (Chicz w
pet al., 1993; Malnati et al., 1992; Rudensky et al., 1991;Figure 5. Alterations in Antigen Presentation Observed in Lamp-2a Overexpressing APC Were Not Due to the Possible Roles of Lamp-2
Protein in Cell Adhesion and Lysosomal Function
(A) Presentation of surface-loaded GAD273–285 was not affected by enhanced plasma membrane Lamp-2a. APCs were fixed with 1% paraform-
aldehyde, incubated with increasing concentrations of GAD273–285 peptide for 12 hr, and then assayed for T cell activation. Similar results
were obtained with live cells and exogenous peptide. Error bars indicate the mean ± the standard deviation.
(B) Unaltered autophagosome labeling in Lamp-2a-overexpressing APC. PriessGAD/Hygro and PriessGAD/LAMP-2a cells were incubated
with 0.05 mM MDC at 37°C for 10 min. After extensive washing, cells were lysed and fluorescence of MDC was measured. Error bars indicate
the mean ± the standard deviation.
(C) Cathepsin D maturation was unaltered in APCs overexpressing Lamp-2a. Cell lysates from PriessGAD/Hygro or PriessGAD/LAMP-2a were
subjected to immunoblot analysis with antibodies specific for human cathepsin D or the HLA-DR α chain.
(D) Subcellular distribution of cathepsin D was unaltered in APC overexpressing Lamp-2a. Membrane organelles prepared from PriessGAD/
Hygro and PriessGAD/LAMP-2a cells were placed on a continuous sucrose gradient for fractionation. Samples were collected and resolved
on SDS-PAGE. Cathepsin D was detected by immunoblotting. Lysosomes are found in gradient fractions 1–4 with prelysosomes and/or late
endosomes in fractions 5–9 and early endosomes in fractions 23–25.ang et al., 1999). The identification of antiviral as well
s tumor-specific CD4 T cells that are reactive with cy-
oplasmic antigens in humans suggests a potential role
or this pathway in host defense. Yet, little is known
oncerning the molecular events that modulate this
ovel pathway for class II antigen presentation. Studies
ndicate that cytoplasmic epitopes derived from au-
oantigens reach class II molecules via an endogenous
athway, with cytosolic proteases playing a role in this
rocessing pathway (Lich et al., 2000; Malnati et al.,
992). Here, specific mechanisms regulating the inter-
ection of cytoplasmic self peptides with MHC class II
olecules were explored by using human B lympho-
lastoid cells. These studies failed to reveal a key role
or TAP in facilitating cytoplasmic peptide delivery to
HC class II molecules. Yet, a lysosomal protein,
amp-2a, and its accessory chaperone, hsc70, were
ound to modulate the efficiency of cytoplasmic pep-
ide and antigen presentation by class II proteins in
hese professional APC.
Encoded within the class II region of the MHC and
nducible by IFN-γ, TAP is well established as a trans-
orter that brings peptides from the cytoplasm to na-
cent MHC class I molecules resident in the ER. TAP
acilitates the delivery of a broad spectrum of peptides,
hich are 8–25 amino acids in length, from the cyto-
lasm into the ER (Androlewicz and Cresswell, 1994).
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577Figure 6. Manipulation of hsc70 Levels in APC Altered Class II Cytoplasmic Antigen Presentation
(A) PriessGAD cells were transfected with a control vector pcDNA3.1/Zeo(−) or vectors encoding sense or antisense human hsc70 cDNA.
PriessGAD/Zeo (control), PriessGAD/hsc (hsc sense), and PriessGAD/as-hsc (hsc antisense) cells were incubated with GAD273–285-specific
33.1 T cells at the ratios indicated for 24 hr. T cell activation was measured as described. Insert: Cell lysates ([1], PriessGAD/Zeo; [2],
PriessGAD/hsc; [3], PriessGAD/as-hsc; 50 g protein/lane) were resolved on 9% SDS-PAGE and analyzed by immunoblotting for hsc70 levels.
*p < 0.05; **p < 0.01, Student’s t test. Results are representative of three to five individual experiments. Error bars indicate the mean ± the
standard deviation.
(B) Coprecipitation of hsc70 and Lamp-2 with GAD antigen. Cell lysate was prepared from PriessGAD cells. Immunoprecipitation was per-
formed with GAD mAb or control Ab. After SDS-PAGE, the presence of hsc70 and Lamp-2 was detected with specific Abs by immunoblotting.Whereas MHC class I molecules incorporate only short
ligands transported via TAP, it remained possible that
newly synthesized MHC class II molecules might also
access the pool of peptides transported by TAP. Human
TAP function was selectively disrupted by constitutive
expression of the viral protein ICP47 in B cells. Class I
protein surface expression and antigen presentation
were diminished by greater than 50%, confirming ICP47
function. Yet, there was no detectable change in the
presentation of three distinct epitopes by MHC class II
molecules, and there was no difference in overall class
II expression observed. These findings are in agree-
ment with earlier studies by Long and colleagues with
human B cells, which suggested that class I null APC
lacking segments of the MHC encoding the genes for
TAP remains capable of presenting cytoplasmic viral
antigens in the context of class II molecules (Malnati et
al., 1992). Studies with murine TAP-deficient melano-
mas transfected to express class II I-Ak and cytoplas-
mic or ER-targeted hen egg lysozyme also failed to de-
tect a role for TAP in class II presentation (Dissanayake
et al., 2005). Yet, class II presentation of epitopes en-
coded within two transmembrane viral glycoproteins
from infectious influenza was reduced in studies with
TAP-deficient murine fibroblasts and dendritic cells
(Tewari et al., 2005). Whether these differences are re-
lated to how antigens are targeted or distributed within
the cytoplasm, or possibly altered mechanisms for
class II presentation of cytoplasmic antigens in distinct
professional and nonprofessional APC, is unknown.
First identified during studies of serum starvation-
induced stress, Lamp-2a and its cofactor hsc70 have
been proposed to function in transporting proteins or
fragments of protein from the cytoplasm into the lyso-
somes for proteolysis (Chiang et al., 1989; Cuervo and
Dice, 1996). This process has been termed chaperone-
mediated autophagy due to a requirement for heat
shock cognate protein hsc70, which is found both inthe cytoplasm and associated with endosomes and
lysosomes. Overexpression of Lamp-2a or hsc70 in hu-
man B cells resulted in enhanced presentation of multi-
ple cytoplasmic epitopes via class II molecules. Simi-
larly, a reduction in hsc70 expression led to diminished
class II presentation of cytoplasmic antigens. Lamp-2
and hsc70 have been observed to bind cytoplasmic
proteins destined for transport and proteolysis. Here,
both Lamp-2a and hsc70 could be detected complexed
with GAD. Changes in exogenous peptide or antigen
presentation were not observed with overexpression of
Lamp-2a or manipulation of cellular hsc70 levels. Yet,
class II presentation of peptides delivered into the cyto-
plasm by electroporation could be enhanced by over-
expression of Lamp-2a. These latter studies suggest
that Lamp-2a can function after partial processing of
antigens to facilitate epitope delivery to class II mole-
cules.
Lamp-2 molecules reside primarily in lysosomes and
prelysosomes (or mature endosomes) but can also be
found at very low levels in early endosomes and at the
plasma membrane (Gough and Fambrough, 1997). The
overexpression of Lamp-2a in B lymphoblastoid cells
resulted in only a very minimal increase in the surface
expression of this protein, with studies ruling out any
potential role for these surface molecules in regulating
APC-T cell interactions. Tumor cell expression of cell
surface Lamp-2 has been proposed to regulate adhe-
sion and possibly metastasis (Ohannesian et al., 1994;
Saitoh et al., 1992). Cells transfected to overexpress
Lamp-2a did not show any alterations in subcellular
morphology or organelle content, as assessed by
transmission electron microscopy, and changes were
not detected in the sorting or maturation of a lysosomal
protease, cathepsin D, in these APC. Consistent with
our failure to detect such changes in lysosomes, func-
tional assays with multiple exogenous antigens (GAD,
human serum albumin, and tetanus toxoid) as well as
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(A) Overexpression of Lamp-2a increased the presentation of cytoplasmic GAD273–285 peptide. FM/Zeo and FM/LAMP-2a cells were incubated
with GAD273–285 (20 M) for 5 min on ice followed by electroporation to deliver this peptide into the cytoplasm. Control cells were not
subjected to electroporation. T cell activation by these APC was measured. *p < 0.05, Student’s t test. Error bars indicate the mean ± the
standard deviation.
(B) Overexpression of Lamp-2a increased the translocation of GAD273–285 peptide from the cytoplasm to MHC class II molecules. FM/Zeo
and FM/LAMP-2a cells were incubated with biotin-GAD273–285 for 5 min on ice followed by electroporation and extensive washing as described
in (A). After culturing for 16 hr, cells were lysed and resolved on SDS-PAGE and transferred to nitrocellulose for detection of biotin-peptide
complexed with class II DR. Streptavidin-HRP was used to detect biotin-GAD273–285 migrating with the MHC class II dimer at 60 kDa. GAPDH
was blotted with anti-GAPDH mAb as a loading control.
(C) The 60 kDa streptavidin-reactive band was only detected in MHC class II-expressing cells. Biotin-GAD273–285 peptides were introduced
into Frev or T2 (MHC class II negative) cells by electroporation. Western blots were performed by using streptavidin-HRP, an antibody specific
for MHC class II dimer and GAPDH.
(D) Depletion of MHC class II dimer from cell lysate decreased the density of the streptavidin-reactive band. After electroporation with biotin-
GAD273–285 and incubation, Frev cell lysates were incubated with anti-HLA-DR antibody (middle lane) or control antibody (right lane) followed
by incubation with protein G sepharose. After depletion by protein G Sepharose, the lysates were subjected to SDS-PAGE for detection of
biotin, MHC class II dimer, or GAPDH. Representative data are shown from three to five separate studies.
(E) After electroporation with biotin-GAD273–285 and extensive washing, Frev cells were incubated at 37°C for variable periods of time as
indicated. Cells were lysed for the detection of biotin-peptide complexed with class II DR.secreted human IgG did not reveal any differences in g
eclass II presentation by cells overexpressing Lamp-2a.
Each of these antigens requires processing within w
cacidic, mature endosomal and lysosomal compart-
ments for efficient class II antigen presentation (Haque s
het al., 2002; Lich et al., 2000; Pathak et al., 2001). These
results strongly suggest that Lamp-2a uniquely regu- a
clates the pathway for cytoplasmic antigen presentation
by MHC class II molecules. t
dHsc70 has been reported to serve multiple functions
in cells. As a chaperone, hsc70 can bind to numerous f
tproteins to mediate both folding and degradation (Ber-
covich et al., 1997; Terada et al., 1995). Cytoplasmic a
dGAD was readily detected bound to hsc70 in B lympho-
blasts expressing this antigen, in line with the potential u
nrole of hsc70 as a cytoplasmic chaperone. Overexpres-
sion of hsc70 in macrophages reportedly enhanced ex- A
bogenous antigen presentation, yet the mechanism was
not investigated (Panjwani et al., 1999). Studies sug- aest that this chaperone protein may be found within
ndosomes and lysosomes in addition to residing
ithin the cytoplasm, with a proposal that this dual lo-
alization may be important in moving proteins into ly-
osomes (Agarraberes et al., 1997). The requirement for
sc70 observed in the current studies of cytoplasmic
ntigen presentation suggests that peptide delivery to
lass II molecules is not via conventional autophagy. In
he latter, components from the cytoplasm are in-
iscriminately engulfed by membrane vacuoles derived
rom the ER. These vacuoles later fuse with or give rise
o lysosomes (Wang and Klionsky, 2003). Conventional
utophagy can be inhibited by treating cells with the
rug 3-methyl adenine (Seglen and Gordon, 1982). By
sing several T cells specific for cytoplasmic antigens,
o change in class II presentation was detected with
PC exposed to this drug (data not shown). However,
ecause of the connection between autophagosomes
nd lysosomes, it remains possible that conventional
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cytoplasmic epitope delivery to class II molecules. Dis-
ruption of autophagy in APC either with this drug or by
other means was reported to inhibit class II presenta-
tion of an expressed bacterial cytoplasmic antigen and
a viral nuclear antigen (Nimmerjahn et al., 2003; Palu-
dan et al., 2005).
Interestingly, Lamp-2b has been suggested to play a
role in regulating conventional autophagy and lyso-
some biogenesis (Nishino et al., 2000). Patients lacking
functional Lamp-2b (Danon disease) accumulate intra-
cellular vacuoles in skeletal and cardiac muscle. In the
current study, overexpression of Lamp-2b failed to in-
fluence endogenous or exogenous antigen presenta-
tion by APC. Yet in APC treated with antisense DNA to
reduce both Lamp-2a and Lamp-2b isoform expres-
sion, exogenous as well as cytoplasmic antigen pre-
sentation by class II molecules was disrupted. Lamp-
2a and Lamp-2b share 94% sequence homology.
Structural differences in Lamp-2a and Lamp-2b are
confined to their transmembrane and cytoplasmic do-
mains. How these domains contribute to the distinct
functions of Lamp-2 isoforms remains unclear.
Recent studies suggest MHC class I and class II
molecules cross over in their access and surveillance
of intracellular and extracellular compartments for anti-
genic peptides derived from pathogens and self. Class
I molecules predominantly display cytoplasm peptides
that have been transported into the ER. Yet, in special-
ized APC such as dendritic cells, these MHC molecules
may also access antigens internalized and processed
within endosomes, lysosomes, and phagosomes (Ack-
erman and Cresswell, 2004; den Haan et al., 2000).
Likewise, class II molecules were traditionally seen as
the primary vehicle for activating immune responses
against extracellular pathogens or self molecules ac-
cessing the endocytic pathway. Yet, the ability of class
II molecules to promote CD4 T helper and cytolytic cell
responses to cytoplasmic antigens derived from vi-
ruses and tumors may, in some cases, be central to
promoting long-lasting, durable protective immunity
(Armstrong et al., 1998; Jacobson et al., 1989). Remark-
ably, many viruses and tumors have evolved mecha-
nisms to disrupt class I presentation via blocking the
translocation of antigenic epitopes by TAP (Ahn et al.,
1997; Fruh et al., 1995; Hengel et al., 1997; Hill et al.,
1995; Lehner et al., 1997). Analysis of Lamp-2a mes-
senger RNA from a wide variety of professional and
nonprofessional APC revealed a broad pattern of con-
stitutive expression (data not shown). Thus, the ability
of class II molecules to access cytoplasmic peptides
via the Lamp-2a:hsc70 complex may represent an im-
portant mechanism by which host cellular responses
can counter viral and tumor immune evasion of the
class I pathway.
Experimental Procedures
Cells
PriessGAD, a B-LCL constitutively expressing GAD, was generated
from Priess (HLA-A2, DR4w4) by retroviral transduction with GAD65
cDNA (Lich et al., 2000). FM cells expressing SMA, a mutant Ig κ
light chain, were generated from the B cell Frev (DR1, DR4w4) by
transfection with a plasmid encoding SMA (Dul et al., 2001). AllB-LCL were cultured in Iscove’s MEM with 10% heat-inactivated
calf serum. The T cell hybridomas recognizing HLA-DR4 epitopes
33.1 (specific for GAD273–285), 2.18 (specific for Ig κ188–203), 1.21
(specific for Ig κ145–159), 17.9 (specific for HSA64–76), and 49.23.2
(specific for an epitope of tetanus toxin) were cultured in RPMI
1640 with 10% fetal calf serum (FCS) and 50 M β mercapto-
ethanol. The CD8 T cell hybridoma 4VA1 specific for HLA-A2 and
influenza A/PR/8/34 matrix M1 (residues 58–66) was maintained in
DMEM with 10% FCS (Canaday et al., 2003). Human CTLs specific
for EBV BMRF1 antigens were maintained for cytolytic assays as
described (Lautscham et al., 2001).
Plasmids and Cell Transfection
The pMCFR-PAC plasmid encoding ICP47 was provided by Dr. P.
Cresswell (Yale University). Human Lamp-2a cDNA and hsc70
cDNA were provided by Drs. J.F. Dice and A.M. Cuervo (Tufts Uni-
versity). Lamp-2a cDNA was transferred into pcDNA/Hygro(+) and
pcDNA/Zeo(−) (Invitrogen). The Lamp-2 antisense vector was gen-
erated by inserting Lamp-2a cDNA (1–658) in an inverted direction
into pcDNAhygro(+). The hsc70 sense vector was generated by in-
serting hsc70 cDNA into pcDNAZeo(−). The hsc70 antisense vector
was generated by inserting hsc70 cDNA (1042–2187) in an inverted
orientation into pcDNAZeo(−). The plasmid encoding SMA cDNA
was a gift from Dr. Y. Argon (University of Pennsylvania). B-LCL,
PriessGAD, or FM was transfected with linearized plasmids (10–20
g/ml) by electroporation (250 V, 950 F). For Lamp-2 isoforms and
hsc70, cells were transfected in three to five independent assays
to ensure reproducible alterations in gene expression and correla-
tion with functional assays. Independently transfected cell lines
were tested by immunoblotting for Lamp-2 and hsc70 protein
steady-state expression, with titrations of 5–100 g of total cell
protein analyzed by immunoblotting with densitometric analysis.
In B cells transfected with Lamp-2 antisense DNA, densitometry
revealed that Lamp-2 protein levels in treated cells were 58% of
that of controls (n = 6). Cells transfected for overexpression of
Lamp-2 on average contained 1.48-fold more of this protein com-
pared with control cells (n = 6). After cell transfection with antisense
DNA for hsc70, residual levels of this protein were 43% compared
with controls (n = 4). Cells transfected for hsc70 overexpression on
average contained 1.38-fold more hsc70 protein than controls (n =
5). All transfectants were checked for class II steady-state and sur-
face expression prior to functional analysis.
Antibodies
Anti-ICP47 rabbit serum was a gift from Dr. D.C. Johnson (Oregon
Health Science University), and commercial antibodies used were
as follows: α-Lamp-2 mAb (H4B4, Developmental Studies Hybri-
doma Bank), α-hsc70 mAb (Maine Biotechnology Service), human
cathepsin D antibody (Calbiochem), anti-GAPDH mAb (Chemicon)
and GAD-specific mAb (Sigma). The mAb DA6.147 recognizing
HLA-DR4 α was provided by Dr. P. Cresswell (Yale University). The
mAb w6/32 recognizes HLA-ABC, and L243 recognizes HLA-DR.
Flow Cytometry
Cells were incubated with w6/32, L243, H4B4, or isotype control
mAbs followed by FITC-conjugated rabbit anti-mouse IgG (Jack-
son ImmunoResearch). Samples were analyzed by flow cytometry
with Cell Quest software.
Immunoblotting
Cells were lysed in 10 mM Trizma Base, 150 mM NaCl, and 1%
Triton X-100 buffer. Samples were resolved on 9% SDS-PAGE and
transferred onto nitrocellulose membrane (Osmonics, Inc.). After
probing with specific antibodies, proteins were visualized by incu-
bation with horseradish peroxidase-conjugated goat-anti-mouse or
goat-anti-rabbit antibodies (Jackson ImmunoResearch Laborato-
ries, Inc.) and ECL (Amersham Pharmacia Biotech).
Immunoprecipitation
Cells were lysed in 10 mM Trizma Base, 150 mM NaCl, 1% octyl
glucoside, 0.2 mM PMSF, 0.1 mM TLCK [pH 7.5] followed by pre-
clearing with rabbit serum and protein G Sepharose. Antibodies
were added to cell lysates at 4°C for 2 hr or overnight, followed by
Immunity
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Hand washed prior to elution and analysis by SDS-PAGE and West-
ern blotting. d
t
Antigen Presentation Assay A
For the cytoplasmic antigen presentation assay, variable numbers a
of APC were incubated with 2 × 104 specific T cells for 24 hr at t
37°C. For exogenous antigen presentation, APC were preincubated
Awith serially diluted antigens for 16 hr at 37°C. 2.5 × 104 APC were
Mthen incubated with 5 × 104 specific T cells for 24 hr. For MHC
tclass I-mediated antigen presentation assays, 1 × 105 APCs were
Binfected with live influenza A/PR/8/34 allantoic fluid (Charles River)
Sby using serial dilutions from 1:50 through 1:400 for 16 hr at 37°C,
dfollowed by coculture with T cells for 24 hr. An IL-2-dependent cell
lline, HT-2, was used to measure IL-2 production following T cell
activation. CTL assays to assess class I presentation of EBV anti- C
gens were completed as described (Lautscham et al., 2001). J
H
Electroporation c
Cells were washed with cold phosphate-buffered saline (PBS)
C
twice and incubated with GAD273–285 peptide or biotin-GAD273–285 f
(20 M) for 5 min on ice. Electroporation (270 V, 125 F, pulse twice)
i
was performed with Bio-Rad Gene Pulser II. Control cells were in-
Ccubated with peptides without electroporation. All cells were
Sextensively washed and cultured at 37°C for 16 hr. Cells were used
pin T cell assays, SDS-PAGE, and/or Western blots to detect biotin-
2GAD273–285:class II complexes.
C
Monodansylcadaverine labeling u
Cells were incubated with 0.05 mM MDC (Sigma) in PBS at 37°C 5
for 10 min (Munafo and Colombo, 2001), washed with PBS, and C
lysed in buffer (10 mM Tris-HCl, 1% Triton X-100 [pH 7.5]). The c
fluorescence intensity was measured at excitation wavelength 380
dnm and emission wavelength 525 nm for triplicate samples. Serum
nstarvation was used as a control to demonstrate increased cellular
Eautophagy and MDC labeling.
D
Subcellular Fractionation P
Sucrose-gradient centrifugation was performed as described e
(Maric et al., 1994). Samples (2 × 108 cells) were homogenized at p
4°C, centrifuged at 900 × g for 10 min, and the supernatant was m
spun at 200 × g above a 1.58 M sucrose cushion for 15 min to D
remove nuclei and mitochondria. Lysates were then centrifuged on (
continuous sucrose gradients (0.47–1.71 M) at 80,000 × g for 20 hr a
at 4°C. Fractions were collected and analyzed by SDS-PAGE and J
Western blot. Specific markers for organelles such as early endo-
Fsomes and lysosomes were detected by immunoblotting (Maric et
Ral., 1994).
t
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